198 related articles for article (PubMed ID: 32197509)
21. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
22. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.
Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM
Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972
[TBL] [Abstract][Full Text] [Related]
23. Proteins Annexin A2 and PSA in Prostate Cancer Biopsies Do Not Predict Biochemical Failure.
Lamb DS; Sondhauss S; Dunne JC; Woods L; Delahunt B; Ferguson P; Murray J; Nacey JN; Denham JW; Jordan TW
Anticancer Res; 2017 Dec; 37(12):6943-6946. PubMed ID: 29187477
[TBL] [Abstract][Full Text] [Related]
24. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
25. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
26. Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases.
Antognelli C; Marinucci L; Frosini R; Macchioni L; Talesa VN
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638532
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion.
Birrane G; Li H; Yang S; Tachado SD; Seng S
Int J Oncol; 2013 Jun; 42(6):1919-28. PubMed ID: 23591596
[TBL] [Abstract][Full Text] [Related]
28. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
29. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.
Koeneman KS; Yeung F; Chung LW
Prostate; 1999 Jun; 39(4):246-61. PubMed ID: 10344214
[TBL] [Abstract][Full Text] [Related]
30. Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin.
Herroon MK; Rajagurubandara E; Diedrich JD; Heath EI; Podgorski I
Sci Rep; 2018 Jan; 8(1):40. PubMed ID: 29311669
[TBL] [Abstract][Full Text] [Related]
31. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
32. Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.
Jeon JM; Kwon OK; Na AY; Sung EJ; Cho IJ; Kim M; Yea SS; Chun SY; Lee JH; Ha YS; Kwon TG; Lee S
PLoS One; 2019; 14(8):e0220807. PubMed ID: 31404090
[TBL] [Abstract][Full Text] [Related]
33. Clinical and prognostic role of annexin A2 in multiple myeloma.
Seckinger A; Meissner T; Moreaux J; Depeweg D; Hillengass J; Hose K; Rème T; Rösen-Wolff A; Jauch A; Schnettler R; Ewerbeck V; Goldschmidt H; Klein B; Hose D
Blood; 2012 Aug; 120(5):1087-94. PubMed ID: 22705595
[TBL] [Abstract][Full Text] [Related]
34. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
35. Wnt5a induces and maintains prostate cancer cells dormancy in bone.
Ren D; Dai Y; Yang Q; Zhang X; Guo W; Ye L; Huang S; Chen X; Lai Y; Du H; Lin C; Peng X; Song L
J Exp Med; 2019 Feb; 216(2):428-449. PubMed ID: 30593464
[TBL] [Abstract][Full Text] [Related]
36. Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.
Labanca E; De Luca P; Gueron G; Paez A; Moiola CP; Massillo C; Porretti J; Giudice J; Zalazar F; Navone N; Vazquez E; De Siervi A
Mol Cancer Res; 2015 Nov; 13(11):1455-64. PubMed ID: 26227317
[TBL] [Abstract][Full Text] [Related]
37. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer.
Sacca P; Meiss R; Casas G; Mazza O; Calvo JC; Navone N; Vazquez E
Br J Cancer; 2007 Dec; 97(12):1683-9. PubMed ID: 18026199
[TBL] [Abstract][Full Text] [Related]
38. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression.
Miller DR; Ingersoll MA; Chou YW; Kosmacek EA; Oberley-Deegan RE; Lin MF
Free Radic Biol Med; 2022 Nov; 193(Pt 1):274-291. PubMed ID: 36265795
[TBL] [Abstract][Full Text] [Related]
40. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
